Nav: Home

New drug helps clear amyloid plaques in Alzheimer's disease patients

November 02, 2016

New research suggests a long-sought amyloid-lowering drug for Alzheimer's disease (AD) may soon be on the horizon. In a phase 1 clinical trial, a compound that blocks the enzyme BACE1, a major AD target, safely reduced toxic β-amyloid in 32 study participants with AD. Unlike other BACE1 inhibitors that cause severe side effects, the new drug proved safe, making it the first oral BACE1 inhibitor to advance to phase 3 trials, which are currently underway. β-amyloid (Aβ) is a sticky peptide that clumps into plaques, which damage the brain of individuals with AD. Blocking BACE1, which plays a key role in the production of Aβ, has emerged as a promising approach to rid the brain of amyloid buildup. However, the search for a brain-penetrant BACE1 inhibitor remains a challenge because of severe toxicity, which can lead to liver damage and further neurodegeneration. Matthew Kennedy and colleagues developed verubecestat, a potent and well-tolerated BACE1 inhibitor. A single dose of the drug markedly reduced levels of Aβ in the blood and cerebrospinal fluid of rats and monkeys. The animals showed no signs of toxicity even after extended treatment. In a phase 1 trial of healthy adults and patients with mild to moderate AD, single and multiple doses of verubecestat lowered Aβ levels without serious side effects. The promising results have helped launched phase 3 trials of the drug investigating its long-term outcomes in AD patients.

American Association for the Advancement of Science

Related Brain Articles:

Scientists predict the areas of the brain to stimulate transitions between different brain states
Using a computer model of the brain, Gustavo Deco, director of the Center for Brain and Cognition, and Josephine Cruzat, a member of his team, together with a group of international collaborators, have developed an innovative method published in Proceedings of the National Academy of Sciences on Sept.
BRAIN Initiative tool may transform how scientists study brain structure and function
Researchers have developed a high-tech support system that can keep a large mammalian brain from rapidly decomposing in the hours after death, enabling study of certain molecular and cellular functions.
Wiring diagram of the brain provides a clearer picture of brain scan data
In a study published today in the journal BRAIN, neuroscientists led by Michael D.
Blue Brain Project releases first-ever digital 3D brain cell atlas
The Blue Brain Cell Atlas is like ''going from hand-drawn maps to Google Earth'' -- providing previously unavailable information on major cell types, numbers and positions in all 737 brain regions.
Landmark study reveals no benefit to costly and risky brain cooling after brain injury
A landmark study, led by Monash University researchers, has definitively found that the practice of cooling the body and brain in patients who have recently received a severe traumatic brain injury, has no impact on the patient's long-term outcome.
More Brain News and Brain Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...